NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.
Int J Hematol
; 115(5): 704-712, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35212915
Full text:
1
Database:
MEDLINE
Main subject:
Thrombocytopenia
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Leukopenia
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Country/Region as subject:
Asia
Language:
En
Journal:
Int J Hematol
Year:
2022
Type:
Article
Affiliation country:
Taiwan